购物车
全部删除
您的购物车当前为空
Ferroptosis-IN-20 (Compound 34a) 是一种靶向电压依赖性阴离子通道 (VDAC) 的 ferroptosis 抑制剂,具有24.2 nM的EC50。它能够抑制 VDAC 的寡聚化和脂质过氧化,降低ROS水平,削弱TFR1介导的铁吸收,抑制 Fe2+浓度,并恢复谷胱甘肽 (GSH) 的水平。Ferroptosis-IN-20 还可减轻叶酸导致的急性肾损伤 (AKI)。
Ferroptosis-IN-20 (Compound 34a) 是一种靶向电压依赖性阴离子通道 (VDAC) 的 ferroptosis 抑制剂,具有24.2 nM的EC50。它能够抑制 VDAC 的寡聚化和脂质过氧化,降低ROS水平,削弱TFR1介导的铁吸收,抑制 Fe2+浓度,并恢复谷胱甘肽 (GSH) 的水平。Ferroptosis-IN-20 还可减轻叶酸导致的急性肾损伤 (AKI)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Ferroptosis-IN-20 相关产品
| 产品描述 | Ferroptosis-IN-20 (Compound 34a) is an inhibitor of ferroptosis targeting voltage-dependent anion channels (VDAC) with an EC50 of 24.2 nM. It prevents VDAC oligomerization and lipid peroxidation. Additionally, Ferroptosis-IN-20 reduces ROS levels, diminishes TFR1-mediated iron uptake, inhibits Fe2+ levels, and restores glutathione (GSH) levels. It also alleviates acute kidney injury (AKI) caused by folic acid. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容